- Home
- PRME vs BOE Comparison
PRME vs BOE Comparison
Compare PRME & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- BOE
- Stock Information
- Founded
- PRME 2019
- BOE 2005
- Country
- PRME United States
- BOE United States
- Employees
- PRME N/A
- BOE N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- BOE Trusts Except Educational Religious and Charitable
- Sector
- PRME Health Care
- BOE Finance
- Exchange
- PRME Nasdaq
- BOE Nasdaq
- Market Cap
- PRME 601.1M
- BOE 643.8M
- IPO Year
- PRME 2022
- BOE N/A
- Fundamental
- Price
- PRME $3.41
- BOE $11.32
- Analyst Decision
- PRME Buy
- BOE
- Analyst Count
- PRME 6
- BOE 0
- Target Price
- PRME $9.31
- BOE N/A
- AVG Volume (30 Days)
- PRME 3.8M
- BOE 166.1K
- Earning Date
- PRME 11-07-2025
- BOE 01-01-0001
- Dividend Yield
- PRME N/A
- BOE 7.30%
- EPS Growth
- PRME N/A
- BOE N/A
- EPS
- PRME N/A
- BOE N/A
- Revenue
- PRME $5,977,000.00
- BOE N/A
- Revenue This Year
- PRME $179.58
- BOE N/A
- Revenue Next Year
- PRME N/A
- BOE N/A
- P/E Ratio
- PRME N/A
- BOE N/A
- Revenue Growth
- PRME 647.13
- BOE N/A
- 52 Week Low
- PRME $1.11
- BOE $8.80
- 52 Week High
- PRME $6.94
- BOE $10.48
- Technical
- Relative Strength Index (RSI)
- PRME 35.80
- BOE 34.97
- Support Level
- PRME $3.45
- BOE $11.50
- Resistance Level
- PRME $4.00
- BOE $11.62
- Average True Range (ATR)
- PRME 0.41
- BOE 0.10
- MACD
- PRME -0.15
- BOE -0.02
- Stochastic Oscillator
- PRME 11.14
- BOE 17.89
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.